Edition:
United States

Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

7.17CNY
14 Feb 2018
Change (% chg)

¥0.01 (+0.14%)
Prev Close
¥7.16
Open
¥7.16
Day's High
¥7.19
Day's Low
¥7.12
Volume
1,850,900
Avg. Vol
4,611,555
52-wk High
¥9.56
52-wk Low
¥6.93

Chart for

About

YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the... (more)

Overall

Beta: 0.72
Market Cap(Mil.): ¥5,650.96
Shares Outstanding(Mil.): 787.04
Dividend: 0.02
Yield (%): 0.28

Financials

  Industry Sector
P/E (TTM): -- 32.23 16.73
EPS (TTM): -- -- --
ROI: -- 14.02 35.60
ROE: -- 15.49 17.23

BRIEF-Yabao Pharma Sees 2017 Net Profit Up 788-818 Pct On Rising Sales Of High Margin Products

* SAYS IT SEES 2017 NET PROFIT UP 788-818 PERCENT Y/Y FROM 225.2 MILLION YUAN ($34.44 million) YEAR AGO Source text in Chinese: http://bit.ly/2l7xYmF Further company coverage: ($1 = 6.5385 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Dec 25 2017

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue

Nov 10 2017

Earnings vs. Estimates